Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Filter Results By

Filter Applied. Clear All
Reset All Filters
Guest Contributor

David Prentice, Ph.D.

Former Vice President and Director of Research for Charlotte Lozier Institute

David A. Prentice is a guest contributor for the Charlotte Lozier Institute.  He is also Advisory Board Chair and a Founding Member for the Midwest Stem Cell Therapy Center, a unique comprehensive stem cell center in Kansas that he was instrumental in creating.  In 2020, he was appointed by the Secretary of HHS to the federal Human Fetal Tissue Ethics Advisory Board.  Dr. Prentice has almost 50 years’ experience as a scientific researcher and professor, including previous service as senior fellow for life sciences at the Family Research Council, Professor of Life Sciences at Indiana State University, Adjunct Professor of Medical and Molecular Genetics, Indiana University School of Medicine, and Adjunct Professor of Molecular Genetics at the John Paul II Institute, Catholic University of America.

He established Stem Cell Research Facts, an educational website providing scientific facts and patient-centered videos about adult stem cells, and is a founding member of Do No Harm: The Coalition of Americans for Research Ethics, and an advisory board member for the Center for Bioethics and Human Dignity.  He has provided scientific advice for numerous medical and science professionals, legislators, policymakers and organizations at the state, federal, and international levels.

Dr. Prentice received his Ph.D. in biochemistry from the University of Kansas, and was at Los Alamos National Laboratory and the University of Texas Medical School-Houston before joining Indiana State University where in addition to his research and teaching, he served as Acting Associate Dean of Arts and Sciences and Assistant Chair of Life Sciences. He was recognized with the University’s Caleb Mills Distinguished Teaching Award and Faculty Distinguished Service Award.  He has taught subjects ranging from non-majors biology to advanced and graduate courses including developmental biology, embryology, cell and tissue culture, history of biology, science and politics, pathophysiology, medical genetics, and medical biochemistry. Several of his courses were also taught on-line.

He received the 2007 Walter C. Randall Award in Biomedical Ethics from the American Physiological Society, given for promoting the honor and integrity of biomedical science through example and mentoring in the classroom and laboratory.  He was honored in 2018 with selection for the 31st A. Kurt Weiss Lectureship on Biomedical Ethics, Oklahoma University Health Science Center. Dr. Prentice’s research interests encompass various aspects of cell growth control, cell and developmental biology; one major focus is adult stem cells.  He has reviewed for various professional publications including The Journal of the American Medical Association.

He is an internationally-recognized expert on stem cell research, cell biology and bioethics, and has provided scientific lectures and policy briefings in 40 states and 21 countries, including testimony before the U.S. Congress and numerous state legislatures, the U.S. National Academy of Sciences, the U.S. President’s Council on Bioethics, European Parliament, British Parliament, Canadian Parliament, Australian Parliament, German Bundestag, French Senate, Swedish Parliament, the United Nations, and the Vatican.  He was selected by President George W. Bush’s U.S. President’s Council on Bioethics to write the comprehensive review of adult stem cell research for the Council’s 2004 publication “Monitoring Stem Cell Research.”

Dr. Prentice has published numerous scientific and bioethics articles, including a review of stem cell science and adult stem cell treatments published in Circulation Research.  He has also published numerous commentaries and op-eds, and travels nationally and internationally to give invited lectures regarding stem cell research, fetal tissue research, gene editing, cloning, embryology, cell and developmental biology, cell culture and vaccines, bioethics, and public policy.  He has been interviewed in virtually all major electronic and print media outlets, including CNN, ABC, NBC, CBS, Fox, CSPAN, Reuters, AP, NPR, USA Today, BBC, The Washington Post, The Los Angeles Times, and The New York Times.

Research Authored

featured-image
Fetal Tissue, Stem Cells & Bioethics

“3-Parent Embryos” and “Gene-Edited Babies”: A Visual Aid

As both international and national debates continue over the ethics and science of "three-parent embryos" and “genetically modified embryos”, Dr. David A. Prentice, Ph.D. of the Charlotte Lozier Institute has prepared a series of visual primers for the general public, illustrating the various methods by which germline genetic engineering is used to create genetically modified human embryos.

featured-image
Fetal Development

Medical and Legal Experts Testify in Support of Ohio’s Pain-Capable Unborn Child Protection Act – Full Written Testimonies

featured-image
Fetal Tissue, Stem Cells & Bioethics

Testimony of David A. Prentice, Ph.D. before Institute of Medicine on Mitochondrial Replacement Therapy and 3-Parent Embryos

I do believe the Committee should consider these proposed techniques as germline modification, and indeed related to modification of nuclear DNA.  It is mistaken to assume that the mitochondrial DNA modifications will not be passed on to future generations when those genetic modifications, as replacements, are made at conception or in the early embryo, as currently envisioned.

featured-image
Fetal Development

Written Testimony of David A. Prentice, Ph.D. in Support of Ohio’s Down Syndrome Non-Discrimination Act

featured-image
Fetal Development

Radio Interview: Dr. David Prentice Explains the Science of Fetal Pain

featured-image
Fetal Tissue, Stem Cells & Bioethics

Written Testimony of David A. Prentice, Ph.D.: Progress on Kansas’ Midwest Stem Cell Therapy Center Research

Stem cell treatments using adult stem cells from bone marrow, umbilical cord blood, and other tissue sources continue to be a cutting-edge medical technology.  I’d like to discuss with you briefly the current state of development for these medical treatments and some examples of their application, the position of the Kansas Stem Cell Center in relation to other centers around the nation, and the view toward the future growth of the Kansas center to bring more treatments to Kansans.

featured-image
Life & the Law

Written Testimony of David A. Prentice, Ph.D. in Support of Indiana’s SB 334

featured-image
Fetal Tissue, Stem Cells & Bioethics

Brave New Britain: The U.K. Approves Production of Three-Parent Embryos

The concept of “designer babies” may sound like science fiction, a literal Brave New World, but it is decidedly not fictional –  it is here now and being pushed rapidly into fertility clinics. After only a brief debate today in the House of Commons, British Members of Parliament (MPs) approved a proposal to create genetically-engineered babies who contain the DNA of three parents.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Living up to Potential: Prospects for a Midwest Center for Stem Cell Therapy

The following is the written testimony of Dr. Prentice before a Joint Meeting of the Committee on Public Health and Welfare, Kansas Senate and the Committee on Health and Human Services, Kansas House.